The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.

Including the name of the #1 company to buy.

Monty Allen Biography and Net Worth

Director of Iradimed

Monty K. Allen CPA serves as Independent Director of the Company. Mr. Allen served as Chief Financial Officer, Secretary and Treasurer of LENSAR, Inc., a medical device business from 2005 through 2011 and continued to serve LENSAR in other capacities until 2016. From 2011 to present, Mr. Allen has served several other businesses as a consultant. Mr. Allen has more than 40 years of accounting and finance experience including service as Chief Financial Officer of three publicly-held companies in biotech, medical and optical technologies. Mr. Allen is a licensed CPA in Florida. Mr. Allen received a B.S. in Accounting and International Business from Florida State University in 1974 and an M.B.A. in General Management from Harvard University in 1978.

What is Monty K. Allen's net worth?: The estimated net worth of Monty K. Allen is at least $940,745.10 as of May 10th, 2023. Mr. Allen owns 17,214 shares of Iradimed stock worth more than $940,745 as of December 22nd. This net worth estimate does not reflect any other investments that Mr. Allen may own. Learn More about Monty K. Allen's net worth.
How do I contact Monty K. Allen?: The corporate mailing address for Mr. Allen and other Iradimed executives is 1025 Willa Springs Dr., Winter Springs FL, 32708. Iradimed can also be reached via phone at (407) 677-8022 and via email at [email protected]. Learn More on Monty K. Allen's contact information.
Has Monty K. Allen been buying or selling shares of Iradimed?: Monty K. Allen has not been actively trading shares of Iradimed during the last quarter. Learn More on Monty K. Allen's trading history.
Who are Iradimed's active insiders?: Iradimed's insider roster includes Monty Allen (Director), James Hawkins (Director), Brent Johnson (VP), Christopher Scott (CFO), Roger Susi (CEO), and Anthony Vuoto (Director). Learn More on Iradimed's active insiders.
Are insiders buying or selling shares of Iradimed?: During the last year, insiders at the medical equipment provider sold shares 2 times. They sold a total of 7,500 shares worth more than $365,450.00. The most recent insider tranaction occured on December, 2nd when CFO John Glenn sold 2,500 shares worth more than $135,450.00. Insiders at Iradimed own 37.1% of the company. Learn More about insider trades at Iradimed.
Information on this page was last updated on 12/2/2024.

Monty K. Allen Insider Trading History at Iradimed

Monty K. Allen Buying and Selling Activity at Iradimed

Iradimed Company Overview

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with RALU ferromagnetic detection device. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.

Today's Range

Now: $54.65

$52.90

$55.15

50 Day Range

MA: $52.97

$48.30

$57.35

2 Week Range

Now: $54.65

$40.18

$57.95

Volume

90,292 shs

Average Volume

48,832 shs

Market Capitalization

$692.58 million

P/E Ratio

37.43

Dividend Yield

1.13%

Beta

0.82

Vladimir Lenin was right…

From Porter & Company | Ad